Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD
Accepted 2026-08-12 16:10:02 ET · period of report 2026-08-11 · accession 0001493152-26-037352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:10 | 2026-08-11 | TAK | Shannon Elaine Mary | Pres, Gbl Supply, Quality | S - Sale | $17.55 | -20.4K | 67.3K | -23% | -$357.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-08-11 | S | D | 20,363 | $17.55 | 67,311 | D | — | — |